Haemonetics | HAE - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Avanos Medical USD 1.9M 100K 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 149M 4M 2026-03
Boston Scientific USD 90M 0 2026-03
Cerus USD 2.33M 96K 2024-06
Cooper Companies USD 20.9M 1.5M 2026-03
Fresenius EUR 81M 5M 2025-09
Fresenius Medical Care EUR 79M 6M 2026-03
Globus Medical USD 5.44B 5.44B 2026-03
Haemonetics USD 7.4M 190K 2025-12
ICU Medical USD 20.64M 21.39M 2025-12
Intuitive Surgical USD 20.11B 58.39B 2026-03
Medtronic USD 176M 5M 2026-03
Merit Medical Systems USD 6.53M 162K 2026-03
Neogen USD 13.9M 356K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Plus Therapeutics USD 62K 25K 2023-12
Quidel USD 5.63B 5.58B 2026-03
ResMed USD 8.79M 14.55M 2025-09
STAAR Surgical USD 800K 799K 2025-09
Steris USD 14.9M 0 2025-12
Stryker USD 46.29B 45.68B 2026-03
Teleflex USD 25.72M 2.43M 2026-03
Terumo JPY 1.53B 1.06B 2026-03
Thermo Fisher Scientific USD 354M 11M 2026-03
US Physical Therapy USD 2.79M 441K 2026-03
Zimmer Biomet Holdings USD 68.8M 3.1M 2026-03